This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Astellas Pharma Gmbh. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2026
Title: Hiroki Ishioka: Innovator in Cardiovascular Pharmaceutical Technologies
Introduction: Hiroki Ishioka, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of cardiovascular medicine. With a focus on developing innovative pharmaceutical compositions, Ishioka strives to address various cardiovascular diseases that impact millions worldwide.
Latest Patents: Ishioka is recognized for his patent on imidazopyridine compounds, specifically designed for treating or preventing various cardiovascular diseases. This pharmaceutical composition enhances soluble guanylate cyclase (sGC) activities, improving cGMP signals. His findings reveal that imidazo[1,2-a]pyridine compounds containing a carbamoyl group at the 3-position and a specific cyclic group at the 8-position via a methyleneoxy group, or a salt thereof, demonstrate sGC activation. This breakthrough makes these compounds valuable as active ingredients in treatments for numerous sGC-related cardiovascular conditions, including peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension.
Career Highlights: Ishioka's career has been marked by his innovative research, particularly with Astellas Pharma GmbH, where he has been able to translate scientific discoveries into practical applications. His single patent provides not only a solution to pressing health issues but also showcases his dedication to improving cardiovascular health.
Collaborations: Ishioka has collaborated with notable colleagues, including Toshio Kurosaki and Tsubasa Watanabe. Together, they have advanced research in pharmaceuticals, particularly focusing on enhancing therapeutic options for cardiac conditions.
Conclusion: Hiroki Ishioka's work exemplifies the vital role of innovation in medicine. His patent on imidazopyridine compounds represents a significant advancement in the treatment of cardiovascular diseases. Through his collaborations and ongoing research efforts at Astellas Pharma GmbH, he continues to contribute to the development of effective therapies that have the potential to improve patients' lives around the globe.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile